Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Simultaneous triple staining for hypoxia, proliferation, and DNA content in murine tumours

Journal Article · · Cytometry
; ;  [1]
  1. Mount Vernon Hospital, Middlesex (United Kingdom)
Hypoxia and proliferation rate are two important biological factors influencing the outcome of radiotherapy regimes for solid tumors. Hypoxic cells are more resistant to radiation than aerobic cells and a rapidly dividing tumor may repopulate faster during treatment. In this article we describe a method to simultaneously measure hypoxia and proliferation using multiparameter flow cytometry. Hypoxic cells were detected using a bioreductively bound marker with an immuno-recognisable side-chain, NITP, and proliferation was measured by bromodeoxyuridine (BrdUrd) incorporation. These parameters were related to cell cycle position by measuring total DNA content with 7-aminoactinomycin D. The data were analysed using single laser excitation on a benchtop flow cytometer. Simultaneous measurement of the three parameters shows the presence of cells which have incorporated BrdUrd and are also hypoxic by the criterion of NITP binding. The murine SaF tumor has a relatively constant aneuploid labelling index of 24%. However, the level of aneuploid hypoxia was variable ranging from 0.8 to 40.9% with a mean value of 15.6%. Within the BrdUrd labelled population there is a range of hypoxia from 2.8 to 28.5% (mean 15.1%); this represents 0.7 to 6.6% of the total tumor population. There are approximately twice as many oxygenated cells than hypoxic cells actively in the cell cycle. In vivo tumors contain cells with S phase DNA content which do not incorporate BrdUrd. This cell population has equivalent proportions of hypoxic and oxic cells. However, there are up to 12-fold more hypoxic cells in the unlabelled S than the BrdUrd labelled population. These data show that proliferation and hypoxia can be measured simultaneously using flow cytometry and the technique may form the basis of a predictive assay for these two important biological determinants of radiotherapy outcome. 24 refs., 2 figs., 4 tabs.
Sponsoring Organization:
USDOE
OSTI ID:
456823
Journal Information:
Cytometry, Journal Name: Cytometry Journal Issue: 4 Vol. 21; ISSN CYTODQ; ISSN 0196-4763
Country of Publication:
United States
Language:
English

Similar Records

Labelling index of human and mouse tumors assessed by bromodeoxyuridine staining in vitro and in vivo and flow cytometry
Journal Article · Thu Oct 31 23:00:00 EST 1985 · Cytometry (Baltimore); (United States) · OSTI ID:5634245

Does DNA cytometry have a place in the clinical laboratory
Conference · Tue Jan 23 23:00:00 EST 1990 · OSTI ID:7246155

Karyotypic heterogeneity and its relation to labeling index in interphase breast tumor cells
Journal Article · Mon May 01 00:00:00 EDT 1995 · Cytometry · OSTI ID:443392